Signifor (pasireotide subcutaneous injection - Novartis) — Cigna

Initial criteria

• Patient is age ≥ 18 years; AND
• According to the prescriber, the patient is not a candidate for surgery OR surgery has not been curative; AND
• The medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of Cushing’s syndrome

Reauthorization criteria

• Patient has had a response, as determined by the prescriber; AND
• Patient is continuing therapy to maintain response

Approval duration

initial 4 months; reauth 1 year